Related Experiment Video
Updated: Jun 17, 2026
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Autophagy-Related Proteins' Immunohistochemical Expression and Their Potential Role as Biomarkers in Thymic
Christina Yfanti1, Georgia Levidou2, Vicky Lampropoulou3
1First Department of Pathology, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Background:
Autophagy, a self-destructive cellular mechanism with a paradoxical nature, plays a part in both tumor suppression and induction by providing cancer cells with metabolic substrates, resulting in cell proliferation and survival. In this study, we aim to investigate the clinical significance of four autophagy pathway components (BECLIN, p62/, LC3b, ATG3) in pathogenetic mechanisms of thymic epithelial tumors (TETs) with possible prognostic importance.
Methods:
Immunohistochemistry was used to evaluate the cytoplasmic expression of BECLIN, p62, LC3b, and ATG3 in tumor cells of 99 TETs, and possible correlations with clinicopathological parameters were examined.
Results:
Higher BECLIN and p62 expression was associated with male gender (p = 0.027 and p = 0.014, respectively). B3 thymomas and thymic carcinomas (TCs) displayed higher p62 expression (p = 0.019), while LC3b expression was marginally higher in non-B3/TC TETs (p = 0.098). A positive correlation between higher BECLIN expression and advanced Masaoka-Koga stage was also observed (p = 0.009). ATG3 was not associated with any of the investigated clinicopathological parameters (p > 0.05). There was also no significant correlation between any of the four examined molecules and overall survival or relapse.
Conclusions:
Our findings indicate autophagy activation in B3/TC and advanced Masaoka-Koga stage cases. Further studies are needed to explore the role of these autophagy related proteins as potential biomarkers and therapeutic targets in TETs.
Insights
Autophagy activation is linked to advanced thymic epithelial tumors (TETs) and specific subtypes. While BECLIN and p62 show correlations, these autophagy markers currently lack prognostic value for survival or relapse in TETs.
Area of Science:
- Oncology
- Cell Biology
- Molecular Pathology
Background:
- Autophagy is a cellular process with dual roles in cancer, potentially promoting or suppressing tumor growth.
- Understanding autophagy's role in thymic epithelial tumors (TETs) is crucial for elucidating their pathogenesis.
- This study investigates key autophagy pathway components in TETs.
Purpose of the Study:
- To assess the clinical significance of BECLIN, p62, LC3b, and ATG3 in thymic epithelial tumors.
- To explore the potential prognostic value of these autophagy markers in TETs.
Main Methods:
- Immunohistochemistry was employed to evaluate the expression of BECLIN, p62, LC3b, and ATG3.
- The study analyzed 99 TET samples.
- Correlations between protein expression and clinicopathological parameters were examined.
Main Results:
- Higher BECLIN and p62 expression correlated with male gender.
- Increased p62 expression was observed in B3 thymomas and thymic carcinomas (TCs).
- BECLIN expression positively correlated with advanced Masaoka-Koga stage; ATG3 showed no significant associations.
Conclusions:
- Autophagy appears activated in B3/TC subtypes and advanced stage TETs.
- Further research is warranted to explore autophagy-related proteins as potential biomarkers and therapeutic targets in TETs.
